Connection

Tanya Turan to Angioplasty

This is a "connection" page, showing publications Tanya Turan has written about Angioplasty.
Connection Strength

2.762
  1. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
    View in: PubMed
    Score: 0.579
  2. Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis. 2017; 43(1-2):31-35.
    View in: PubMed
    Score: 0.494
  3. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
    View in: PubMed
    Score: 0.410
  4. The CASSISS Randomized Clinical Trial. Stroke. 2023 01; 54(1):286-289.
    View in: PubMed
    Score: 0.187
  5. Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis of Peri-Procedural and Long-Term Risk. Neurosurgery. 2020 06 01; 86(6):755-762.
    View in: PubMed
    Score: 0.158
  6. Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg. 2010 May; 51(5):1081-7.
    View in: PubMed
    Score: 0.156
  7. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.100
  8. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
    View in: PubMed
    Score: 0.097
  9. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
    View in: PubMed
    Score: 0.093
  10. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg. 2013 Nov; 5(6):528-33.
    View in: PubMed
    Score: 0.093
  11. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
    View in: PubMed
    Score: 0.085
  12. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg. 2009 Jul; 1(1):35-9.
    View in: PubMed
    Score: 0.074
  13. Treatment of atherosclerotic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):2257-61.
    View in: PubMed
    Score: 0.073
  14. Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis. 2008; 5(3):117-24.
    View in: PubMed
    Score: 0.067
  15. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.040
  16. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.029
  17. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.